Inventor · disambiguated record
Omid Veiseh
Also filed as: VEISEH OMID
21 granted patents·34 pending applications·82 citations·filing 2006–2024
94Inventor score
Files withMASSACHUSETTS INST TECHNOLOGY20UNIV RICE WILLIAM M12SIGILON THERAPEUTICS INC9UNIV NORTHWESTERN4UNIV WASHINGTON3
Top patents by PatentIndex Score
55 records- 0194US10898443B2Modified alginates for anti-fibrotic materials and applicationsMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Jan 26, 2021·4 cites·19 claims
- 0293US10709818B2Modified alginates for anti-fibrotic materials and applicationsMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Jul 14, 2020·5 cites·35 claims
- 0392US11090413B2Modified alginates for anti-fibrotic materials and applicationsMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Aug 17, 2021·4 cites·25 claims
- 0492US10786446B2Multi-layer hydrogel capsules for encapsulation of cells and cell aggregatesMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Sep 29, 2020·4 cites·20 claims
- 0592US10172791B2Multi-layer hydrogel capsules for encapsulation of cells and cell aggregatesMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Granted Jan 8, 2019·11 cites·28 claims
- 0692US9555007B2Multi-layer hydrogel capsules for encapsulation of cells and cell aggregatesTHE CHILDREN'S MEDICAL CENTER CORP·Filed 2013·Granted Jan 31, 2017·17 cites·23 claims
- 0791US11446239B2Multi-layer hydrogel capsules for encapsulation of cells and cell aggregatesMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Sep 20, 2022·2 cites·20 claims
- 0891US11266606B2Modified alginates for anti-fibrotic materials and applicationsMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Mar 8, 2022·2 cites·17 claims
- 0990US8778310B2Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancerZHANG MIQIN·Filed 2007·Granted Jul 15, 2014·12 cites·14 claims
- 1089US10835486B2Multi-layer hydrogel capsules for encapsulation of cells and cell aggregatesMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Nov 17, 2020·3 cites·20 claims
- 1189US10426735B2Modified alginates for anti-fibrotic materials and applicationsMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Oct 1, 2019·8 cites·14 claims
- 1289US2025222177A1Modified alginates for anti-fibrotic materials and applicationsMASSACHUSETTS INST TECHNOLOGY·Filed 2024·Application pending·0 cites
- 1383US10729818B2Modified alginates for anti-fibrotic materials and applicationsMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Aug 4, 2020·1 cites·23 claims
- 1483US2025090725A1Materials with improved propertiesMASSACHUSETTS INST TECHNOLOGY·Filed 2024·Application pending·0 cites
- 1581US10730983B2Biocompatible coatings and hydrogels for reducing foreign body response and fibrosisMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Aug 4, 2020·2 cites·44 claims
- 1680US11945786B2Compounds, devices, and uses thereofSIGILON THERAPEUTICS INC·Filed 2017·Granted Apr 2, 2024·2 cites·11 claims
- 1779US12097307B2Modified alginates for anti-fibrotic materials and applicationsMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Sep 24, 2024·0 cites·22 claims
- 1878US12161760B2Implantable particles and related methodsSIGILON THERAPEUTICS INC·Filed 2019·Granted Dec 10, 2024·2 cites·27 claims
- 1978US10683379B2Polymers, hydrogels, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Jun 16, 2020·2 cites·28 claims
- 2074US11307197B2Polyarginine-coated magnetic nanovector and methods of use thereofUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2016·Granted Apr 19, 2022·1 cites·13 claims
- 2172US2025235409A1Implantable particles and related methodsSIGILON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2268US2024189505A1Hybrid bioelectronic/engineered cell wearable system for therapeutic agents delivery and applications thereofUNIV NORTHWESTERN·Filed 2022·Application pending·0 cites
- 2366US2024254507A1Engineered cells for producing of therapeutic agents to be delivered by a hybrid bioelectronic deviceUNIV NORTHWESTERN·Filed 2022·Application pending·0 cites
- 2465US2025136910A1Devices for use as blood brain barrier modelsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 2564US2024207508A1Hybrid bioelectronic/engineered cell implantable system for therapeutic agents delivery and applications thereofUNIV NORTHWESTERN·Filed 2022·Application pending·0 cites
- 2664US2014241993A1Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancerUNIV WASHINGTON·Filed 2014·Application pending·0 cites
- 2764US2010260686A1Nanoparticles for brain tumor imagingUNIV WASHINGTON·Filed 2009·Application pending·0 cites
- 2863US12186453B2Materials with improved biocompatibilityMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Jan 7, 2025·0 cites·22 claims
- 2962US2024041939A1Encapsulated cells expressing il-12 and uses thereofUNIV RICE WILLIAM M·Filed 2022·Application pending·0 cites
- 3062US2024415931A1Methods of use and administration of encapsulated cellsUNIV RICE WILLIAM M·Filed 2022·Application pending·0 cites
- 3161US2007154965A1Chlorotoxin-labeled nanoparticle compositions and methods for targeting primary brain tumorsZHANG MIQIN·Filed 2006·Application pending·0 cites
- 3259US2024189458A1Methods for in vivo delivery of microbes to human microenvironmentsUNIV RICE WILLIAM M·Filed 2022·Application pending·0 cites
- 3359US2023265149A1Encapsulated cells expressing il-2 and uses thereofUNIV RICE WILLIAM M·Filed 2022·Application pending·0 cites
- 3458US2025367371A1Hybrid bioelectronic/engineered cell implantable system for therapeutic agents delivery and applications thereofUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 3558US2024041755A1Implantable constructs for modulating an immune responseUNIV RICE WILLIAM M·Filed 2021·Application pending·0 cites
- 3657US2013302252A1Polyarginine-coated magnetic nanovector and methods of use thereofUNIV WASHINGTON CT COMMERCIALI·Filed 2013·Application pending·0 cites
- 3755US2022042100A1Quantifying foreign dna in low-volume blood samples using snp profilingUNIV RICE WILLIAM M·Filed 2019·Application pending·0 cites
- 3855US2025281672A1Identification of pro- and anti-inflammatory lipids relating to immune response to medical implantsUNIV RICE WILLIAM M·Filed 2022·Application pending·0 cites
- 3954US2025000788A1Biocompatible devices for cell-based therapies and related methodsSIGILON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4053US2022411795A1Engineered cells for controlled productionUNIV RICE WILLIAM M·Filed 2020·Application pending·0 cites
- 4153US2024301093A1Triazole containing polymers and methods of use thereofUNIV RICE WILLIAM M·Filed 2022·Application pending·0 cites
- 4253US2017246347A1Materials with improved propertiesMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Application pending·0 cites
- 4351US9784730B2Nanoparticle for targeting brain tumors and delivery of O6-benzylguanineUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2014·Granted Oct 10, 2017·0 cites·19 claims
- 4450US2021353781A1Surface-modified cells, methods of making and usingMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Application pending·0 cites
- 4550US2022313599A1Implantable constructs and uses thereofUNIV RICE WILLIAM M·Filed 2020·Application pending·0 cites
- 4648US2023210908A1Methods for improved delivery of therapeutic agentsUNIV RICE WILLIAM M·Filed 2021·Application pending·0 cites
- 4747US2023123802A1Compositions, devices, and methods for factor vii therapySIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4846US2021145889A1Methods, compositions, and implantable elements comprising stem cellsSIGILON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4945US2015320890A1Nanoparticles for brain tumor imagingUNIV WASHINGTON·Filed 2015·Application pending·0 cites
- 5044US2022000789A1Implantable devices for cell therapy and related methodsSIGILON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Omid Veiseh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →